scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1043907864 |
P356 | DOI | 10.1186/S13041-015-0154-6 |
P932 | PMC publication ID | 4604618 |
P698 | PubMed publication ID | 26462472 |
P5875 | ResearchGate publication ID | 283237006 |
P2093 | author name string | Martin Stangel | |
Kurt-Wolfram Sühs | |||
Refik Pul | |||
Thomas Skripuletz | |||
Kirsten Müller-Vahl | |||
Philipp Schwenkenbecher | |||
Sascha Alvermann | |||
P2860 | cites work | Caspr2, a new member of the neurexin superfamily, is localized at the juxtaparanodes of myelinated axons and associates with K+ channels | Q22011028 |
Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan's syndrome and acquired neuromyotonia | Q24623766 | ||
Connecting the CNTNAP2 Networks with Neurodevelopmental Disorders | Q28086930 | ||
Pathogenetic role of autoantibodies in neurological diseases | Q28138484 | ||
Neuronal surface glycolytic enzymes are autoantigen targets in post-streptococcal autoimmune CNS disease | Q28579383 | ||
Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study | Q33551430 | ||
Anti-striatal antibodies in Tourette syndrome cause neuronal dysfunction | Q33924303 | ||
Antistreptococcal, neuronal, and nuclear antibodies in Tourette syndrome | Q34191070 | ||
CNTNAP2 is disrupted in a family with Gilles de la Tourette syndrome and obsessive compulsive disorder | Q34206301 | ||
Striatal microinfusion of Tourette syndrome and PANDAS sera: failure to induce behavioral changes | Q34312538 | ||
Increased antistreptococcal antibody titers and anti-basal ganglia antibodies in patients with Tourette syndrome: controlled cross-sectional study | Q34565885 | ||
Disruption of the CNTNAP2 gene in a t(7;15) translocation family without symptoms of Gilles de la Tourette syndrome. | Q34613441 | ||
Antibody binding to neuronal surface in Sydenham chorea, but not in PANDAS or Tourette syndrome | Q34923513 | ||
Immunopathogenic mechanisms in tourette syndrome: A critical review | Q34974740 | ||
Prevalence and sociodemographic correlates of antinuclear antibodies in the United States | Q35899088 | ||
Morphologic features of the amygdala and hippocampus in children and adults with Tourette syndrome | Q36536119 | ||
Pathogenic and physiological autoantibodies in the central nervous system | Q38020957 | ||
Oligoclonal bands in cerebrospinal fluid in patients with Tourette's syndrome | Q38339949 | ||
Increased serum levels of interleukin-12 and tumor necrosis factor-alpha in Tourette's syndrome | Q40436503 | ||
Antineuronal antibodies in a group of children with obsessive-compulsive disorder and Tourette syndrome | Q42504305 | ||
Dramatic improvement after rituximab in a patient with paraneoplastic treatment-refractory Morvan syndrome associated with anti-CASPR2 antibodies | Q46189503 | ||
The relationship between group A streptococcal infections and Tourette syndrome: a study on a large service-based cohort | Q48297494 | ||
Seroprevalence of autoantibodies against brain antigens in health and disease | Q48774317 | ||
Prevalence and clinical correlates of tic disorders in a community sample of school-age children. | Q50997227 | ||
P433 | issue | 1 | |
P921 | main subject | Tourette syndrome | Q191779 |
P304 | page(s) | 62 | |
P577 | publication date | 2015-10-13 | |
P1433 | published in | Molecular Brain | Q6895938 |
P1476 | title | Gilles de la Tourette syndrome is not linked to contactin-associated protein receptor 2 antibodies | |
P478 | volume | 8 |
Q89879264 | Alterations in the Nervous System and Gut Microbiota after β-Hemolytic Streptococcus Group A Infection-Characteristics and Diagnostic Criteria of PANDAS Recognition |
Q92106211 | Immunity in Gilles de la Tourette-Syndrome: Results From a Cerebrospinal Fluid Study |
Q90379777 | Intravenous Immunoglobulin Treatment Did Not Improve Tics in a Patient With Gilles de la Tourette Syndrome and Intrathecal Antibody Synthesis |
Search more.